Patents by Inventor Tuula A. Ryde

Tuula A. Ryde has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110165251
    Abstract: The present invention relates to liquid dosage compositions of stable nanoparticulate active agents. The liquid dosage compositions of the invention include osmotically active crystal growth inhibitors that stabilize the nanoparticulate active agents against crystal and particle size growth of the active agent.
    Type: Application
    Filed: March 9, 2011
    Publication date: July 7, 2011
    Inventors: H. William BOSCH, Matthew R. HILBORN, Douglas C. HOVEY, Laura J. KLINE, Robert W. LEE, John D. PRUITT, Niels P. RYDE, Tuula A. RYDE, Shuqian XU
  • Publication number: 20080241070
    Abstract: Disclosed are redispersible fibrate, such as fenofibrate, dosage forms. Also disclosed are in vitro methods for evaluating the in vivo effectiveness of fibrate, such as fenofibrate, dosage forms. The methods utilize media representative of in vivo human physiological conditions.
    Type: Application
    Filed: March 28, 2008
    Publication date: October 2, 2008
    Inventors: Tuula A. Ryde, Evan E. Gustow, Stephen B. Ruddy, Rajeev Jain, Rakesh Patel, Michael John Wilkins, Niels P. Ryde
  • Publication number: 20040258757
    Abstract: The present invention relates to liquid dosage compositions of stable nanoparticulate active agents. The liquid dosage compositions of the invention include osmotically active crystal growth inhibitors that stabilize the nanoparticulate active agents against crystal and particle size growth of the active agent.
    Type: Application
    Filed: July 16, 2003
    Publication date: December 23, 2004
    Applicant: Elan Pharma International, Ltd.
    Inventors: H. William Bosch, Matthew R. Hilborn, Douglas C. Hovey, Laura J. Kline, Robert W. Lee, John D. Pruitt, Niels P. Ryde, Tuula A. Ryde, Shuqian Xu
  • Publication number: 20040156895
    Abstract: Disclosed are solid dosage forms of active agents and pullulan. The solid dosage form has a friability of less than about 1%.
    Type: Application
    Filed: November 12, 2003
    Publication date: August 12, 2004
    Applicant: Elan Pharma International Ltd.
    Inventors: John D. Pruitt, Douglas C. Hovey, Tuula A. Ryde, H. William Bosch, Robert W. Lee